Skip to content

Trigonella, Foeniculum, Chichorium, Hornleum and Glycine in prevention of cancer-induced cachexia/anorexia

Evaluation of herbal combination consists of Trigonella, Foeniculum, Chichorium, Hornleum and Glycine in the prevention of cancer-induced cachexia/anorexia of solid tumors’ patients: a randomized, double-blinded, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180722040556N1
Enrollment
60
Registered
2019-05-28
Start date
2018-07-26
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-induced cachexia. C80.0

Interventions

Intervention group: Herbal combination including Trigonella, Foeniculum, Chichorium, Hornleum, and Glycine provided in Dineh company named General Tonic, one sachet three times a day for four weeks.

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All adult patients (18 years and older) with advanced solid tumor malignancies (Stage 3-4) who encountered cancer-induced anorexia or weight loss (equal or greater than 5% of the previous weight before cancer diagnosis or within the last two months). Cancer patients with serum creatinine < 2 mg / dl. Cancer patients with serum total bilirubin < 2 mg / dl. Patients haven't had any sign of dysphagia or gastrointestinal obstruction. We have expected patients to be alive at least 3 upcoming months. Patients who have received high doses of megestrol due to cachexia and anorexia simultaneously.

Exclusion criteria

Exclusion criteria: Patients who have undergone major surgery for the last 4 weeks. Patients with a history of thrombophlebitis diseases. Patients who have been taking systemic corticosteroid within the last 4 weeks or concurrently. Patients who have cognitive impairment, psychiatric disorder or brain metastasis leading to cognitive impairment. Patients who have diabetes, uncontrolled blood pressure or advanced heart failure (NYHA 4) Patients who have consumed chronic alcohol. Patients who are pregnant or breast-feeding. Patients with a known hypersensitivity reaction to one of the plants in considered herbal combination

Design outcomes

Primary

MeasureTime frame
Evaluation of herbal combination consists of Trigonella, Foeniculum, Chichorium, Hornleum, and Glycine in the prevention of cancer-induced cachexia/anorexia. Timepoint: Baseline and 4 weeks later. Method of measurement: Edmonton criteria.

Secondary

MeasureTime frame
Quality of life. Timepoint: Baseline and four weeks later. Method of measurement: Iranian Version of the EORTC QLQ.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzadeh Moghaddas

Esfahan University of Medical Sciences

azadeh_moghaddas@yahoo.com+98 31 3792 7074

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026